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Abstract: Six nickel(II) complexes of the N2O2 chelating thiosemicarbazones were synthesized using N1-4-benzyloxysalicylidene-Smethyl/propyl thiosemicarbazone and methoxy-substitute-salicylaldehydes in the presence of Ni(II) ion by template reaction. The
structures of thiosemicarbazones and nickel(II) complexes were characterized by elemental analysis, UV-Vis, IR, and 1H-NMR spectroscopies. The structure of the N1-4-benzyloxysalicylidene-S-propyl thiosemicarbazone (2) was determined by X-ray single-crystal
diffraction method. The total antioxidant capacities of synthesized compounds were evaluated by using cupric reducing antioxidant
capacity (CUPRAC) method. The thiosemicarbazones exhibited more potent antioxidant capacity than Ni(II) complexes. Trolox equivalent antioxidant capacity (TEAC) of 1c was found highest in tested nickel(II) complexes. In addition, antioxidant activities of tested
compounds were evaluated by using the hydroxyl radical, DPPH radical, and ABTS radical scavenging abilities of these compounds.
Key words: Thiosemicarbazone, nickel(II) complex, structural analysis, antioxidant capacity, radical scavenging activity

1. Introduction
Thiosemicarbazide, N1H2–NH–C(=S)–N4H2, is an important precursor used in the synthesis of many polydentate ligands
[1–3]. The reactivity of its two terminal amino groups differ from each other [4]. The amino functional group of the molecule (N1H2-) is more reactive and easily condenses with the 2-hydroxy/amino substitute carbonyl compounds to form
schiff bases [5–7]; whereas, the thioamidic group (-N4H2) has a very weak potential to react with carbonyl compounds.
However, by performing a double-condensation reaction in the presence of transition metal ions having template effect
and a second carbonyl molecule, thiosemicarbazone-metal complexes with tetradentate coordination can be obtained
[8–10]. These compounds were first synthesized and characterized in 1971 [11].
The biological activities of thiosemicarbazones and their metal complexes have been known for a long time [12–15]. In
addition, there is a significant amount of published studies describing the role of their uses as sensors [16,17], optics [18],
and catalysts [19]. Many studies have revealed that the activities depend on the type of metal and the substituted groups
attached to hydrazine, amide and sulfur atoms [20,21]. Therefore, it becomes important to systematically synthesize and
examine compounds with different groups on both the aromatic ring and the amide and sulfur atoms. When the biological activity studies of thiosemicarbazone and metal complexes are examined, studies containing antioxidant activity are
remarkable. In studies examining the antioxidant activities of thiosemicarbazones and nickel (II) complexes containing
–OH groups in the aromatic rings, 3/4–hydroxy salicylaldehyde or 2,2′-dihydroxybenzophenone, it was observed that the
activity was high due to the presence of these groups [22–24]. In order to examine how methoxy and benzyloxy groups
affect the antioxidant activity; we synthesized six new nickel(II) complexes (Figure 1) using N1-4-benzyloxysalicylideneS-methyl/proyl-thiosemicarbazones and 3-, 4-, and 5-methoxy salicylaldehydes. The structure of the N1-4-benzyloxysalicylidene-S-propyl thiosemicarbazone (2) has been determined by X-ray diffraction method. Besides, we examined the
antioxidant capacities and radical scavenging activities of the free thiosemicarbazones and nickel(II) complexes in vitro
assays for summarize their biochemical properties.
2. Materials and methods
2.1. Materials and physical measurements
The chemicals used were of reagent grade and used without purification. Analytical data were determined on a ThermoFinnigan Flash EA 1112 Series Elementary Analyzer. Electronic spectra of the compounds were recorded at 5×10–5 M
* Correspondence: songul@istanbul.edu.tr
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Figure 1. Synthesis scheme for the nickel(II) complexes.
1a : (R1:CH3; R2: 3-OCH3); 1b: (R1:CH3; R2: 4-OCH3); 1c: (R1:CH3; R2: 5-OCH3)
2a: (R1:C3H7; R2: 3-OCH3); 2b: (R1:C3H7; R2: 4-OCH3); 2c: (R1:C3H7; R2: 5-OCH3)

concentration in CHCL3 solution with a Shimadzu 2600 UV-Vis Spectrometer. Infrared spectra were obtained on an
Agilent Carry 630 FTIR-ATR spectrophotometer in range of 4000 to 400 cm−1 at room temperature. 1H-NMR spectra were
performed on a Bruker Avance-500 model spectrometer relative to SiMe4. The X-ray data were recorded on a Bruker APEX
II QUAZAR three-circle diffractometer.
2.2. Synthesis of thiosemicarbazones
The thiosemicarbazones were obtained according to literature methods with small modifications [25], and synthesis
procedure was described as follows by the N1-4-benzyloxysalicylidene-S-methylthiosemicarbazone (1) as representative
example. 0.5 g (5 mmol) thiosemicarbazide and 0.33 mL (5 mmol) methyl iodide were refluxed in 10 mL ethanol for 2 h.
Three milliliters of ethanolic solution of 4-benzyloxysalicylaldehyde (1.25 g, 5 mmol) was added. The mixture was refluxed
two more hours and allowed to stand at room temperature overnight. The separated yellow precipitate was filtered, washed
several times with cold ethanol and dried under vacuum. The N1-4-benzyloxysalicylidene-S-propyl thiosemicarbazone
(2) was obtained by using 1-bromopropane (5 mmol, 0.45 mL) with the same procedure. Hydrohalide forms of the
thiosemicarbazones were used in the synthesis of complexes. The colors, m.p. (°C), yields (%), elemental analyzes, UV-Vis,
IR and 1H-NMR data of the thiosemicarbazones are given as follows:
N1-4-benzyloxysalicylidene-S-methylthiosemicarbazone (1): Light yellow, 134 °C, 63%, Anal. Found (Calc.)
for C16H18IN3O2S (443.30 g/mol) C, 43.21 (43.35); H, 4.19 (4.09); N, 9.33 (9.48); S, 7.65 (7.53)%. UV-Vis (nm, log ε in
parenthesis): 240 (2480); 294 (2300); 305 (2840). IR (ATR, cm-1): υ(OH) 3457; υs(NH2) 3281; ʋ(CH)aliph. 2786, 2646; υ(C=N1)
1602. 1H NMR (CDCl3): 11.53, 11.31 (s, 1H, i:2/1, OH); 8.33, 8.20 (s, 1H, i:2/1 CH=N1); 7.39-7.07 (m, 8H, aromatics); 6.51
(m, 2H, NH2); 5.03 (s, 2H, O-CH2); 2.48 (s, 3H, S-CH3).
N1-4-benzyloxysalicylidene-S-propylthiosemicarbazone (2): Light yellow, 115 °C, 66%, Anal. Found (Calc.) for
C18H22BrN3O2S (424.35 g/mol) C, 50.81 (50.95); H, 5.19 (5.23); N, 9.73 (9.90); S, 7.65 (7.56)%. UV-Vis (nm, log ε in
parenthesis): 240 (6900); 294 (6440); 305 (7800). IR (ATR, cm-1): υ(OH) 3365; υs(NH2) 3332; ʋ(CH)aliph. 2879, 2791; υ(C=N1)
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1539. 1H NMR (CDCl3): 11.76, 11.56 (s, 1H, i:1/2, OH); 8.31, 8.18 (s, 1H, i:2/1 CH=N1); 7.39-7.06 (m, 8H, aromatics); 6.50
(m, 2H, NH2); 5.01 (s, 2H, O-CH2); 3.00, 2.98 (t, 2H, i:3/1, J:7.32 S-CH2-); 1.68 (m, 2H, -CH2-); 1.02, 0.81 (t, 3H, J:7.32,
i:2/1, -CH3).
2.3. Synthesis of the complexes
The nickel(II) complexes were obtained according to literature methods with small modifications [6], and synthesis procedure
was described as follows by the N1-benzyloxysalicylidene-N4-3-methoxysalicylidene-S-methylthiosemicarbazidato
nickel(II) (1a) as representative example. N1-4-benzyloxysalicylidene-S-methylthiosemicarbazone (0.44 g, 1 mmol) and
3-methoxysalicylaldehyde (0.15 g, 1 mmol) were dissolved in 25 ml warm ethanol and added to the ethanolic solution
of nickel(II) chloride hexahydrate (0.23 g, 1 mmol) by stirring. The mixture was stirred at 40 °C for two hours and than
allowed to stand at room temperature for a few days. The red product was collected by filtration and washed with cold
ethanol. The crystalline powders were dried over P2O5 under vacuum. The other nickel complexes were synthesized with
the same procedure described above using N1-4-benzyloxysalicylidene-S-propylthiosemicarbazone and 4-/5-methoxy
substitue salicylaldehydes. The colors, m.p. (°C), yields (%), elemental analyzes, UV-Vis, IR and 1H-NMR data of the
nickel(II) complexes are given as follows:
N1-benzyloxysalicylidene-N4-3-methoxysalicylidene-S-methylthiosemicarbazidato nickel(II) (1a): Red, 270 °C,
72%, Anal. Found (Calc.) for C24H21N3NiO4S (506.20 g/mol) C, 56.74 (56.95); H, 4.31 (4.18); N, 8.19 (8.30); S, 6.38 (6.33)%.
UV-Vis (nm, log ε in parenthesis): 240 (10860); 294 (10520); 305 (12960); 505 (6040). IR (ATR, cm-1): ʋ(CH)aliph. 2935,
2916; υ(C=N1) 1599; υ(C=N2) 1530.1H NMR (DMSO-d6): 8.39, (s, 1H, CH=N1); 8.20, (s, 1H, CH=N4); 7.48-6.40 (m, 11H,
aromatics); 5.15 (s, 2H, O-CH2); 3.84 (s, 3H, O-CH3); 2.70 (s, 3H, S-CH3).
N1-benzyloxysalicylidene-N4-4-methoxysalicylidene-S-methylthiosemicarbazidato nickel(II) (1b): Red, 284 °C,
70%, Anal. Found (Calc.) for C24H21N3NiO4S (506.20 g/mol) C, 56.81 (56.95); H, 4.27 (4.18); N, 8.22 (8.30); S, 6.26 (6.33)%.
UV-Vis (nm, log ε in parenthesis): 242 (7700); 295 (7920); 305 (9720); 499 (5880). IR (ATR, cm-1): ʋ(CH)aliph. 2901, 2866;
υ(C=N1) 1539; υ(C=N2) 1500.1H NMR (DMSO-d6): 8.34, (s, 1H, CH=N1); 8.06, (s, 1H, CH=N4); 7.65-6.39 (m, 11H,
aromatics); 5.14 (s, 2H, O-CH2); 3.81 (s, 3H, O-CH3); 2.68 (s, 3H, S-CH3).
N1-benzyloxysalicylidene-N4-5-methoxysalicylidene-S-methylthiosemicarbazidato nickel(II) (1c): Red, 269 °C,
69%, Anal. Found (Calc.) for C24H21N3NiO4S (506.20 g/mol) C, 57.01 (56.95); H, 4.31 (4.18); N, 8.44 (8.30); S, 6.49 (6.33)%.
UV-Vis (nm, log ε in parenthesis): 242 (12260); 294 (12540); 305 (15460); 510 (6800). IR (ATR, cm-1): ʋ(CH)aliph. 2891,
2872; υ(C=N1) 1599; υ(C=N2) 1517.1H NMR (DMSO-d6): 8.33, (s, 1H, CH=N1); 8.07, (s, 1H, CH=N4); 7.44-6.27 (m, 11H,
aromatics); 5.10 (s, 2H, O-CH2); 3.72 (s, 3H, O-CH3); 2.65 (s, 3H, S-CH3).
N1-benzyloxysalicylidene-N4-3-methoxysalicylidene-S-propylthiosemicarbazidato nickel(II) (2a): Red, 197 °C,
66%, Anal. Found (Calc.) for C26H25N3NiO4S (534.25 g/mol) C, 58.31 (58.45); H, 4.63 (4.72); N, 8.01 (7.87); S, 6.19 (6.00)%.
UV-Vis (nm, log ε in parenthesis): 244 (7640); 294 (7880); 305 (9780); 522 (5160). IR (ATR, cm-1): ʋ(CH)aliph. 2927, 2861;
υ(C=N1) 1536; υ(C=N2) 1498.1H NMR (DMSO-d6): 8.39, (s, 1H, CH=N1); 8.28, (s, 1H, CH=N4); 7.49-6.41 (m, 11H,
aromatics); 5.15 (s, 2H, O-CH2); 3.75 (s, 3H, O-CH3); 3.28, (t, 2H, J:0.015, S-CH2-); 1.77 (m, 2H, -CH2-); 1.01 (t, J:0.014 3H,
-CH3).
N1-benzyloxysalicylidene-N4-4-methoxysalicylidene-S-propylthiosemicarbazidato nickel(II) (2b): Red, 186 °C,
53%, Anal. Found (Calc.) for C26H25N3NiO4S (534.25 g/mol) C, 58.51 (58.45); H, 4.59 (4.72); N, 7.81 (7.87); S, 5.86 (6.00)%.
UV-Vis (nm, log ε in parenthesis): 244 (9860); 294 (9878); 306 (12460); 509 (7860). IR (ATR, cm-1): ʋ(CH)aliph. 2926,
2866; υ(C=N1) 1597; υ(C=N2) 1590.1H NMR (DMSO-d6): 8.31, (s, 1H, CH=N1); 8.08, (s, 1H, CH=N4); 7.63-6.37 (m, 11H,
aromatics); 5.13 (s, 2H, O-CH2); 3.81 (s, 3H, O-CH3); 3.24, (t, 2H,J:0.015, S-CH2-); 1.72 (m, 2H, -CH2-); 1.00 (t, 3H, J:0.017,
-CH3).
N1-benzyloxysalicylidene-N4-5-methoxysalicylidene-S-propylthiosemicarbazidato nickel(II) (2c): Red, 205 °C,
51%, Anal. Found (Calc.) for C26H25N3NiO4S (534.25 g/mol) C, 58.61 (58.45); H, 4.79 (4.72); N, 7.91 (7.87); S, 6.11 (6.00)%.
UV-Vis (nm, log ε in parenthesis): 244 (9860); 294 (9870); 306 (12460); 511 (7860). IR (ATR, cm-1): ʋ(CH)aliph. 2928, 2866;
υ(C=N1) 1541; υ(C=N2) 1490.1H NMR (DMSO-d6): 8.37, (s, 1H, CH=N1); 8.26, (s, 1H, CH=N4); 7.48-6.39 (m, 11H,
aromatics); 5.13 (s, 2H, O-CH2); 3.71 (s, 3H, O-CH3); 3.28, (t, 2H, J:0.015, S-CH2-); 1.74 (m, 2H, -CH2-); 1.01 (t, 3H, J:0.014,
-CH3).
2.4. Antioxidant property analysis
Different spectrophotometric assays were performed to evaluate the antioxidant properties of N1-4-benzyloxysalicylideneS-methyl/propyl-thiosemicarbazones and nickel(II) complexes. CUPRAC (cupric reducing antioxidant capacity) method
[26, 27] was used for total antioxidant capacity determination. The CUPRAC method is based on the reduction of a Cu
(II) -Nc complex to a yellow-orange colored Cu (I) -Nc solution in the presence of antioxidants and a measurement of
absorbance at 450 nm. Results were reported as trolox equivalent antioxidant capacity (TEAC). The free radical scavenging
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activities of synthesized compounds were determined by the DPPH method [28]. The DPPH activities were evaluated with
respect to inhibition percentage of DPPH radical at 517 nm after reaction with a given samples. ABTS (2,2’- azinobis-(3ethylbenzothiazoline-6-sulfonic acid))/persulfate method [29] was used to measure the antioxidant activity of synthesized
compounds. This method is based on the inhibition of absorbance of the chromogenic radical cation of ABTS (ABTS.+)
by antioxidants. Antioxidant activity was determined as a percentage inhibition of ABTS.+ with respect to the decrease
in the absorbance of the ABTS.+ within a certain period of time in the presence of antioxidants. Hydroxyl radicals in the
aqueous medium were produced through the Fenton system, and the hydroxyl radical scavenging (HRS) activities of
the samples were determined using the modified CUPRAC method [30]. The initial concentration of each sample in the
ABTS.+ scavenging, DPPH scavenging and HRS activity determinations were used to be 10-3 M. In these tests, 0.5 mL were
taken from the samples for all three methods. All antioxidant tests were carried out in triplicate.
2.5. X-ray crystallography
The crystals of 2 suitable for X-ray diffraction analysis were obtained by slow evaporation of an ethanol solution at room
temperature. A light yellow crystal of 2, C18H22BrN3O2S, having approximate dimensions of 0.32 × 0.06 ×0.03 mm, was
mounted on a glass fiber. All measurements were made on a Bruker APEX-II CCD imaging plate area detector with
graphite monochromatic Mo-K αradiation (λ= 0.71073Å). Experimental conditions were summarized in Table 1. The

Table 1. Crystal data and structure refinement for compound 2.
Parameters
CCDC deposition no.

2034512

Chemical formula

C18H22BrN3O2S

Formula weight (g.mol )

424.35

Temperature (K)

296.15

Wavelength (Å)

0.71073

Crystal system

monoclinic

Space group

P21/c

-1

Unit cell parameters
a, b, c (Å)

4.9253(12), 38.615(10), 10.353(3)

b (°)

100.907(18)

Volume (Å )

1933.4(8)

Z

4

3

Dcalc (g.cm )

1.458

Absorption correction

multi-scan

Tmin, Tmax

0.850, 0.937

F(000)

872.0

Crystal size (mm3)

0.327 x 0.060 x 0.029

-3

Diffractometer/measurement method
Index ranges h,k,l

-5<=h<=5, -42<=k<=45, -12<=l<=12

2θ Range for data collection (°)

6.330° < 2θ < 50.048°

Reflections collected

22042

Independent reflections

3416 [Rint = 0.1081, Rsigma = 0.0955]

Refinement method

Full-matrix least-squares on F2

Data/restraints/parameters

3416 / 21 / 239

Goodness-of-fit on F

1.014

Final R indexes [I>=2σ (I)]

R1 = 0.0556, wR2 = 0.1236

R indices (all data)

R1 = 0.1474, wR2 = 0.1592

2
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crystal structure was solved and refined with SHELXTL [31]. The non-hydrogen atoms were refined anisotropically. H
atoms were located in geometrically idealized positions C-H = 0.95(6) Å and treated as riding and U iso (H) = 1.2 U eq
(C). The intra-intermolecular interactions were given in Table 2. Drawing was performed with the program ORTEP-III
[32] with 50% probability displacement ellipsoid. ORTEP and unit cell packing diagram for 2 were given in Figures 2 and
3. The hydrogen-bond network was shown in Figure 4. Crystallographic data (excluding structure factors) for the structure
in this paper has been deposited in the Cambridge Crystallographic Data Centre as supplementary publication number
CCDC-2034512 for 2. Copies of the data can be obtained, free of charge, via www.ccdc.cam.ac.uk/conts/retrieving.html
or from the Cambridge Crystallographic Data Centre, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; fax: + 44 1223
336033. E-mail: deposit@ccdc.cam.ac.uk.
3. Results
3.1. Some physical properties of the compounds
The colour of S-alkylthiosemicarbazones, obtained as crystalline powders, are light yellow. They are soluble in common
organic solvents such as alcohols, chloroform, dichloromethane, dimethyl sulfoxide etc. The red colored nickel(II) complexes are stable in the air. For thiosemicarbazones and nickel(II) complexes, the methyl substitute derivatives have higher
melting point than those with propyl substitution.
3.2. Spectral analysis
In the UV-Vis spectra of thiosemicarbazones the band observed at 240 nm is attributed to π→π* transition belonging to
substitute benzene group. n→π* transitions associated with the imine group of thiosemicarbazone moiety are recorded at
294 and 305 nm [33, 34]. These bands were also detected at 240–244 nm and 294–306 nm in the spectra of the complexes.
The metal→ligand charge transfer transitions were seen at 499–522 nm as weak absorption bands [22].
In the infrared spectra of thiosemicarbazones, the υ(OH) and υ(NH) bands were recorded at 3457, 3365 cm–1 and
3281, 3332 cm–1 for 1, 2 respectively. These bands were not present in the spectra of nickel(II) complexes because of the
Table 2. Intra-intermolecular interactions (Å, °).
D—H····A

D—H

H····A

D····A

D—H····A

C2-H2····O1

0.930

2.710

3.47(1)

139.9

C5-H5····C8

0.931

2.849

3.42(8)

120.6

C17-H17B····S1

0.970

2.628

3.57(1)

164.9

C16-H16A····Br1

0.971

2.912

3.79(7)

151.8

N1-H1C····Br1

0.890

2.634

3.33(5)

135.4

N1-H1A····Br1

0.890

2.673

3.35(5)

133.3

*O1-H1····N3

0.821

1.907

2.63(6)

147.0

Figure 2. ORTEP diagram of compound 2 showing the labelling scheme of all atoms with 50% probability level.
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Figure 3. A partial packing diagram of the compound 2 in unit cell.

Figure 4. Hydrogen-bond network.

coordination of the phenolic oxygen and amidic nitrogen. The strong υ(C=N1) bands of compounds were observed at
1536–1602 cm–1 range [35]. In the spectra of complexes, new azomethine bands, υ(C=N4), were monitored at 1490–1590
cm–1 range due to the condensation of thioamide nitrogen and second aldehyde [36]. In addition, the aliphatic υ(CH)
bands were observed at 2646–2935 cm–1 range [37].
When 1H-NMR spectra of thiosemicarbazones are examined, the proton of the phenolic hydroxyl group appeared as
singlet at 11.53,11.31 ppm (for 1) and 11.76, 11.56 ppm (for 2) in different isomer ratios. The absence of these peaks in their
complex spectra supports that the coordination is through phenolic oxygen [38]. In addition, the isomerism of the CH=N1
group, which was recorded as singlet in the range of 8.33–8.18 ppm in the spectra of thiosemicarbazones, was not observed
in the spectra of the complexes due to hindered rotation around C=N1 and C=N4 double bond on complexation [39].
The peaks of the new CH=N4 group formed as a result of the template reaction were observed as singlets in the spectra
of nickel(II) complexes in the range of 8.28–8.06 ppm [40]. Also, recording the peaks of methoxy substituted aldehyde at
expected values supports its contribution in complex formation.
3.3. Crystallography
The single crystal of N1-4-benzyloxysalicylidene-S-propylthiosemicarbazone (2) were grown by slow evaporation of the
ethanolic solution. The thiosemicarbazone crystallize in the monoclinic P21/c space group. The ortep diagram of the

840

EĞLENCE-BAKIR / Turk J Chem
compound with displacement ellipsoids drawn at 50% probability level is given in Figure 2. Crystal data and structure
refinement details are given in Table 1. In addition, the networks showing unit cell and intermolecular/intramolecular
hydrogen bonds are given in Figure 3 and Figure 4. The intra-intermolecular interactions are listed in Table 2 [41].
Accordingly, there are intramolecular hydrogen bond interaction between O1-H1∙∙∙∙∙∙N3 atoms with the distance of 1.907 Å.
The structure includes a thiosemicarbazone cation with one counter bromide ion. The structure of the thiosemicarbazone
contain hydrogen-bromide bonding interactions between bromide ions and the H1A and H1C atoms of ammonium group
of the cationic moiety with the bond distances 2.634 and 2.673 Å for N1-H1C∙∙∙∙∙Br1 and N1-H1A∙∙∙∙∙Br1, respectively.
3.4. Antioxidant properties analysis
The CUPRAC method [26] was applied to N1-4-benzyloxysalicylidene-S-methyl/propyl-thiosemicarbazones and nickel(II)
complexes in comparison with the trolox standard reference compound. The linear equations (A = mC + n), correlation
coefficients (r), and linear concentration ranges of tested compounds summarized in Table 3. The TEAC values of the
ligands and complexes can be seen in Figure 5. Their trolox equivalent antioxidant capacities (TEAC coefficients) were
calculated from the ratio of the slope of the calibration curve of each compounds to that of trolox.
The TEAC coefficients of the ligands were 1.02 and 1.12, as 1 and 2, respectively. The TEAC coefficients of the Ni(II)
complexes with methyl derivatives were 0.67, 0.30 and 0.54, as 1a, 1b and 1c, respectively. The TEAC coefficients of the
Ni(II) complexes with propyl derivatives were 0.36, 0.54 and 0.45, as 2a, 2b and 2c, respectively. When the synthesized
compounds were compared with trolox as reference, the TEAC values of thiosemicarbazones (1 and 2) were higher than

Table 3. The TEAC (trolox equivalent antioxidant capacity) coefficients of the compounds with respect to the CUPRAC assay.
Sample

Working range

Calibration equation

Correlation coefficient (r) TEAC

1

–5

6.1 × 10 – 3.0 × 10

A = 17034 c + 0.130

0.9918

1.02 ± 0.05

2

6.1 × 10–6 – 3.0 × 10–5

A = 18644 c + 0.119

0.9894

1.12 ± 0.01

1a

1.1 × 10 – 5.5 × 10

A = 11242 c + 0.165

0.9946

0.67 ± 0.03

1b

1.2 × 10–5 – 6.1 × 10–5

A = 5098 c + 0.052

0.9956

0.30 ± 0.04

1c

–5

1.1 × 10 – 5.5 × 10

A = 9166 c + 0.046

0.9933

0.54 ± 0.01

2a

1.1 × 10–5 – 5.5 × 10–5

A = 6008 c + 0.017

0.9880

0.36 ± 0.04

2b

–5

1.1 × 10 – 5.5 × 10

A = 9067 c - 0.007

0.9976

0.54 ± 0.06

2c

6.1 × 10–6 – 3.0 × 10–5

A = 7604 c - 0.019

0.9923

0.45 ± 0.02

–6

–5

–5

–5

–5

Trolox εN: 1.67 x 104 L mol–1 cm–1

Figure 5. TEAC values of the compounds.
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trolox (TEACtrolox=1.0). The nickel(II) complexes (1a-c and 2a-c) exhibited less antioxidant activity with lower TEAC
coefficients. Also, when the TEAC values are examined, it is seen that the thiosemicarbazones are about twice as high
as their antioxidant capacities compared to its nickel complexes. The position of the methoxy group in the benzene ring
in nickel complexes affects the antioxidant capacity. When we examine the methyl derivatives of nickel(II) complexes,
the high antioxidant capacity was obtained when the methoxy group was in 3th position, on the other hand, when we
examined propyl derivatives, it was in the 4th position of the methoxy group.
Hydroxyl radicals were produced by reacting the iron-EDTA complex with H2O2. Hydroxyl radicals attack salicylate
under acidic conditions, yielding a yellow product with Cu(II) -Nc. The added radical scavengers compete with salicylate
for the produced hydroxyl radical and reduce chromophore formation from Cu(II)-Nc. HRS activity as inhibition ratio
of the tested compounds was summarized in Table 4. When the HRS activities of the tested compounds were examined,
it was found that there was no significant difference between the thiosemicarbazones and nickel complexes. On the other
hand, the highest HRS activity belongs to 1 with 63.77% and the lowest belongs to 2b with 51.14%.
DPPH scavenging activities of the tested compounds also represent free radical scavenging activities. When Table 4
was examined, it can be seen that DPPH scavenging activities of propyl derivatives of Ni(II) complexes are higher than
their methyl derivatives and free thiosemicarbazones. The highest DPPH scavenging activity belongs to 2c with 61.52%.
The ABTS radical scavenging activities of the tested compounds are summarized in Table 4 as percentage inhibition
rate. ABTS radical scavenging activities of thiosemicarbazones were significantly higher compared to nickel(II) complexes.
The results of ABTS radical scavenging activities of tested compounds were parallel with the antioxidant capacity results
in view of ranking. Since ABTS radical scavenging activity also uses for total antioxidant capacity determination in the
literature, it confirms the parallelism between CUPRAC results and ABTS radical scavenging activities obtained in the
study. The highest ABTS scavenging activity belongs to 2 with 70.89% and the lowest belongs to 2a with 21.98%.
4. Conclusion
Six new nickel(II) template complexes with N2O2 chelating thiosemicarbazones were synthesized with appreciable yield of
between 51%–72%. The structural characterizations of all compounds were carried out by using analytical and spectroscopic
methods. The structure of N1-4-benzyloxysalicylidene-S-methylthiosemicarbazone (2) was confirmed by X-ray diffraction
method. The compounds were investigated for the effect of alkyl chain and the position of the methoxy group of the second
aldehyde on antioxidant activity. The thiosemicarbazones exhibited more potent antioxidant capacity than nickel(II)
complexes. This is probably due to the fact that thiosemicarbazones have non-coordinated -NH2 and -OH groups, which
allow the coordination of Cu(II) ion in CUPRAC method. With the formation of the complex, the thiosemicarbazones
have coordinated with the nickel(II) ion via these groups. Thus, the antioxidant activity of the nickel(II) complexes is lower
as expected. In the S-methyl derivative complexes, the high antioxidant capacity was obtained in the 1a where the methoxy
group is in the 3th position. However, when S-propyl derivative complexes were examined for radical scavenging activity,
highest activity was obtained in the 2b where the methoxy group is in the 4th position. In addition, it was observed that
the radical scavenging activities of thiosemicarbazones were mostly higher than Ni(II) complexes, except DPPH activities.
As can be seen, the synthesis of thiosemicemicarbazone derivatives and metal complexes with different substitutions plays
an important role in obtaining the desired structure.
Acknowledgment and/or disclaimers, if any
This work was supported by the Scientific Research Projects Coordination Unit of İstanbul University, Turkey (Project
Number: 22832).

References
1.

Weinert M, Prostenik M, Stanecev NZ. Identification of normal, higher aliphatic aldehydeby means of the melting point data of the
thiosemicarbazone. Croatica Chemica Acta 1962; 34: 1-6.

2.

Padhye S, Kauffman GB. Transition metal complexes of semicarbazones and thiosemicarbazones. Coordination Chemistry Reviews 1985;
63: 127-160. doi:10.1016/0010-8545(85)80022-9

3.

Takjoo R, Hashemzadeh A, Rudbari HA, Nicola F. Copper(II) and molybdenum(VI) complexes with 5-bromosalicylaldehyde
S-allylisothiosemicarbazone: Syntheses, characterizations and crystal structures. Journal of Coordination Chemistry 2013; 66 (2): 343357. doi:10.1080/00958972.2012.748191

842

EĞLENCE-BAKIR / Turk J Chem
4.

Revenco MD, Palamarciuc OV, Bourosh PN, Lipkowski J, Gdaniec M et al. New template reactions of salicylaldehyde S-methylisothiosemicarbazone with 2-formylpyridine promoted by Ni(II) or Cu(II) metal ions. Inorganica Chimica Acta 2011; 368: 157-164.
doi:10.1016/j.ica.2010.12.068

5.

Eğlence-Bakır S, Şahin M, Salt BZ, Tüzün E, Mataracı-Kara E et al. Palladium (II) complexes with thione and thioalkylated
thiosemicarbazones: Electrochemical, antimicrobial and thermogravimetric investigations. Spectrochimica Acta Part A: Molecular and
Biomolecular Spectroscopy 2020; 237: 118358. doi:10.1016/j.saa.2020.118358

6.

Şahin M, Eğlence-Bakır S, Alpay M, Alpay S, Özmerdivenli R et al. Effective copper (II) and nickel (II) complexes with N3O and ON3
thiosemicarbazidato ligands. Synthesis, structural analysis and in vitro cytotoxity on melanoma B16F10 cells. Inorganica Chimica Acta
2020; 502: 119347. doi:10.1016/j.ica.2019.119347

7.

Kalaivani P, Prabhakaran R, Kaveri MV, Huang R, Staples RJ et al. Synthesis, spectral, X-ray crystallography, electrochemistry, DNA/
protein binding and radical scavenging activity of new palladium(II) complexes containing triphenylarsine. Inorganica Chimica Acta
2013; 405: 415-426. doi:10.1016/j.ica.2013.06.038

8.

Leovac VM, Gerbeleu NV, Canic VD. Coordination compounds of cobalt (III), chromium (III), and vanadium (III) with salicylaldehyde
S-methylthiosemicarbazone. Russian Journal of Inorganic Chemistry 1982; 27: 514-517.

9.

Meghdadi S, Amirnasr M, Majedi M, Bagheri M, Amiri A et al. Template synthesis, and X-ray crystal structures of copper(II)and nickel(II)
complexes of new unsymmetrical tetradentate Schiff base ligands. Electrochemistry, antibacterial properties, and metal ion effection
hydrolysis–recondensation of the ligand. Inorganica Chimica Acta 2015; 437: 64-69. doi:10.1016/j.ica.2015.08.006

10.

Bal-Demirci T, Şahin M, Kondakçı E, Özyürek M, Ülküseven B et al. Synthesis and antioxidant activities of transition metal complexes
based 3-hydroxysalicylaldehyde-S-methylthiosemicarbazone. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
2015; 138: 866-872. doi:10.1016/j.saa.2014.10.088

11.

Gerbeleu V, Revenco MD. Russian Journal of Inorganic Chemistry 1971; 16: 1046.

12.

Bavin EM, Rees RJW, Robson JM, Seiler M, Seymour DE et al. The tuberculostatic activity of some thiosemicarbazones. Journal of
Pharmacy and Pharmacology 1950; 2 (1): 764-772. doi:10.1111/j.2042-7158.1951.tb13043.x

13.

Pelosi G, Bisceglie F, Bignami F, Ronzi P, Schiavone P et al. Antiretroviral activity of thiosemicarbazone metal complexes. Journal of
Medicinal Chemistry 2010, 53 (24): 8765-8769. doi:10.1021/jm1007616

14.

Gou Y, Wang J, Chen S, Zhang Z, Zhang Y et al. α-N-heterocyclic thiosemicarbazone Fe (III) complex: Characterization of its antitumor
activity and identification of anticancer mechanism. European Journal of Medicinal Chemistry 2016; 123: 354-364. doi:10.1016/j.
ejmech.2016.07.041

15.

Qi J, Yao Q, Qian K, Tian L, Cheng Z et al. Synthesis, antiproliferative activity and mechanism of gallium (III)-thiosemicarbazone complexes
as potential anti-breast cancer agents. European Journal of Medicinal Chemistry 2018; 154: 91-100. doi:10.1016/j.ejmech.2018.05.016

16.

Kumar SM, Dhahagani K, Rajesh J, Nehru K, Annaraj J et al. Synthesis, characterization, structural analysis and DNA binding studies of
nickel(II)–triphenylphosphine complex of ONS donor ligand–Multisubstituted thiosemicarbazone as highly selective sensor for fluoride
ion. Polyhedron 2013; 59: 58-68. doi:10.1016/j.poly.2013.04.048

17.

Tang L, Zhou P, Zhang Q, Huang Z, Zhao J et al. A simple quinoline derivatized thiosemicarbazone as a colorimetic and fluorescent sensor
for relay recognition of Cu2+ and sulfide in aqueous solution. Inorganic Chemistry Communications 2013; 36: 100-104. doi:10.1016/j.
inoche.2013.08.011

18.

Tian Y-P, Yu W-T, Zhao C-Y, Jiang M-H, Cai Z-G et al. Structural characterization and second-order nonlinear optical properties of zinc
halide thiosemicarbazone complexes. Polyhedron 2002; 21: 1217-1222. doi:10.1016/S0277-5387(02)01004-5

19.

Youssef NS, El-Seidy AMA, Schiavoni M, Castano B, Ragaini F et al. Thiosemicarbazone copper complexes as competent catalysts for
olefin cyclopropanations. Journal of Organometallic Chemistry 2012; 714: 94-103. doi:10.1016/j.jorganchem.2012.03.018

20.

Li MX, Chen CL, Ling CS, Zhou J, Ji BS et al. Cytotoxicity and structure–activity relationships of four α-N-heterocyclic thiosemicarbazone
derivatives crystal structure of 2-acetylpyrazine thiosemicarbazone. Bioorganic & Medicinal Chemistry Letters 2009; 19: 2704-2706.
doi:10.1016/j.bmcl.2009.03.135

21.

Şahin M, Özdemir N, Bal-Demirci T, Ülküseven B, Dinçer M et al. Structural and spectroscopic characterization of a thiosemicarbazi
datodioxouranium(VI) complex: A combined experimental and DFT study. Spectrochimica Acta Part A: Molecular and Biomolecular
Spectroscopy 2015; 135: 994-1001. doi:10.1016/j.saa.2014.08.008

22.

Bal-Demirci T, Şahin M, Özyürek M, Kondakçı E, Ülküseven B. Synthesis, antioxidant activities of the nickel(II), iron(III) and oxovanadium(IV) complexes with N2O2 chelating thiosemicarbazones. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
2014; 126: 317-323. doi:10.1016/j.saa.2014.02.039.

23.

Bal-Demirci T, Şahin M, Kondakçı E, Özyürek M, Ülküseven B et al. Synthesis and antioxidant activities of transition metal complexes based 3-hydroxysalicylaldehyde-S-methylthiosemicarbazone. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2015;
138: 866-872. doi:10.1016/j.saa.2014.10.088.

843

EĞLENCE-BAKIR / Turk J Chem
24.

İlhan-Ceylan B. Oxovanadium(IV) and Nickel(II) complexes obtained from 2,2′-dihydroxybenzophenone-S-methyl-thiosemicarbazone:
Synthesis, characterization, electrochemistry, and antioxidant capability. Inorganica Chimica Acta 2020; 517: 120816. doi:10.1016/j.
ica.2020.120186

25.

Eğlence S, Şahin M, Özyürek M, Apak R, Ülküseven B. Dioxomolybdenum(VI) complexes of S-methyl-5-bromosalicylidene-N-alkyl
substituted thiosemicarbazones: Synthesis, catalase inhibition and antioxidant activities. Inorganica Chimica Acta 2018; 469: 495-502.
doi:10.1016/j.ica.2017.10.007

26.

Apak R, Güçlü K, Özyürek M, Karademir SE. Novel total antioxidant capacity index for dietary polyphenols and vitamins C and E, using
their cupric ion reducing capability in the presence of neocuproine: CUPRAC method. Journal of Agricultural and Food Chemistry
2004; 52 (26): 7970-7981. doi:10.1021/jf048741x

27.

Kaya Y, Erçağ A, Koca A. New square-planar nickel(II)-triphenylphosphine complexescontaining ONS donor ligands: Synthesis,
characterization, electrochemical and antioxidant properties. Journal of Molecular Structure 2020; 1206: 127653. doi:10.1016/j.
molstruc.2019.127653

28.

Sánchez‐Moreno C, Larrauri JA, Saura‐Calixto F. A procedure to measure the antiradical efficiency of polyphenols. Journal of the Science
of Food and Agriculture 1998; 76 (2): 270-276. doi:10.1002/(SICI)1097-0010(199802)76:2<270::AID-JSFA945>3.0.CO;2-9

29.

Re R, Pellegrini N, Proteggente A, Pannala A, Yang M et al. Antioxidant activity applying an improved ABTS radical cation decolorization
assay. Free radical biology and medicine 1999; 26 (9-10): 1231-1237. doi:10.1016/S0891-5849(98)00315-3

30.

Özyürek M, Bektaşoğlu B, Güçlü K, Apak R. Hydroxyl radical scavenging assay of phenolics and flavonoids with a modified cupric
reducing antioxidant capacity (CUPRAC) method using catalase for hydrogen peroxide degradation. Analytica Chimica Acta 2008; 616
(2): 196-206. doi:10.1016/j.aca.2008.04.033

31.

SHELXTL, version 6.14, Bruker AXS Inc.: Madison, WI; 2000.

32.

Farrugia L. J. ORTEP-3 for Windows-a version of ORTEP-III with a graphical user interface (GUI). Journal of Applied Crystallography
1997; 30 (5): 565-565. doi:10.1107/S0021889897003117

33.

Eğlence-Bakır S, Saçan Ö, Şahin M., Yanardağ R, Ülküseven B. Dioxomolybdenum(VI) complexes with 3-methoxy salicylidene-N-alkyl
substituted thiosemicarbazones. Synthesis, characterization, enzyme inhibition and antioxidant activity. Journal of Molecular Structure
2019; 1194: 35-41. doi:10.1016/j.molstruc.2019.05.077

34.

Kumar LV, Nath GR. Synthesis, characterization and biological studies of cobalt(II), nickel(II), copper(II) and zinc(II) complexes of
vanillin-4-methyl-4-phenyl-3-thiosemicarbazone. Journal of Chemical Sciences 2019; 131: 76. doi:10.1007/s12039-019-1658-x

35.

Fetoh A, Mohammaed MA, Youssef MM, El-rash GMA. Characterization, cyclic voltammetry and biological studies of divalent Co, Ni
and Cu complexes of water-soluble, bioactive and photoactivethiosemicarbazone salt. Journal of Molecular Liquids 2019; 287: 110958.
doi:10.1016/j.molliq.2019.110958

36.

Jacob JM, Prathapachandra-Kurup MR, Nisha K, Serdaroğlu G, Kaya S. Mixed ligand copper(II) chelates derived from an O, N, Sdonortridentate thiosemicarbazone: Synthesis, spectral aspects, FMO, and NBO analysis. Polyhedron 2020; 189: 114736. doi:10.1016/j.
poly.2020.114736

37.

Bhowmick AC, Bikash DN, Moim MI. coordination complexes of transition metals and schiff base with potent medicinal activity.
American Journal of Chemistry 2019; 9 (4): 109-114. doi:10.5923/j.chemistry.20190904.01

38.

Güveli Ş, Nickel(II)-PPh3 complexes of substituted benzophenone thiosemicarbazones: Electrochemistry, structural analysis, and
antioxidant properties. Journal of Coordination Chemistry 2020; 73 (1): 137-153. doi:10.1080/00958972.2020.1711888

39.

Şahin M, Koca A, Özdemir N, Dinçer M, Büyükgüngör O et al. Synthesis, X-ray crystal structures, thermal and electrochemical properties
of thiosemicarbazidatodioxouranium(VI) complexes. Dalton Transactions 2010; 39: 10228-10237. doi:10.1039/C0DT00265H

40.

Takjoo R, Centore R, Akbari A, Ahmadi M. Square planar nickel(II) complexes derived from 5-bromo-2-hydroxybenzaldehyde
S-ethylisothiosemicarbazone: Preparation, characterization and structural studies. Polyhedron 2014; 80: 243-249. doi:10.1016/j.
poly.2014.04.055

41.

Desiraju G. R. and Steiner T. The Weak Hydrogen Bond: In Structural Chemistry and Biology. 2001; Vol. 9. International Union of Crystal.

844

